Free semaglutide reconstitution calculator. Enter vial size (2-10 mg), BAC water volume, and weekly dose to get concentration, syringe units, and doses per vial. Includes the 5-tier dose escalation schedule (0.25-2.4 mg weekly), unit conversion reference, and B12 compound guidance. Verify semaglutide quality with independent lab test data on Peptigrity.
A 5 mg vial of semaglutide reconstituted with 2 mL of bacteriostatic water gives a concentration of 2.5 mg/mL, or 25 mcg per unit on a U-100 syringe. For a 0.25 mg dose, draw the syringe to 10.0 units (0.10 mL). At that dose the vial provides about 20 doses.
Defaults (5 mg vial, 2 mL, 0.25 mg) carried over unchanged from this calculator's live defaults (2 September 2026); the 2 mL volume matches this page's own FAQ and escalation table. Arithmetic only, not a recommendation.
Draw the syringe up to
That's one 250 mcg dose. Add 2 mL of water to your 5 mg vial first.
| Step | Dose | Draw on a U-100 | Doses per vial |
|---|---|---|---|
| Tier 1 (start) | 250 mcg | 10 units | 20 |
| Tier 2 | 500 mcg | 20 units | 10 |
| Tier 3 | 1 mg | 40 units | 5 |
| Tier 4 | 1.70 mg | 68 units | 2 |
| Tier 5 (max) | 2.40 mg | 96 units | 2 |
Tap any row to load that dose into the calculator above.
The FDA-approved dose escalation for semaglutide (Ozempic for type 2 diabetes, Wegovy for weight management) starts at 0.25 mg once weekly and increases every 4 weeks. Compounded lyophilised semaglutide follows the same tiers - the difference is manual reconstitution and syringe measurement.
| Escalation Tier | Weekly Dose | Weeks | At 2.5 mg/mL | At 5 mg/mL |
|---|---|---|---|---|
| Tier 1 (starting) | 0.25 mg | Weeks 1-4 | 10 units | 5 units |
| Tier 2 | 0.5 mg | Weeks 5-8 | 20 units | 10 units |
| Tier 3 | 1.0 mg | Weeks 9-12 | 40 units | 20 units |
| Tier 4 | 1.7 mg | Weeks 13-16 | 68 units | 34 units |
| Tier 5 (Wegovy max) | 2.4 mg | Week 17+ | 96 units | 48 units |
At 5 mg/mL, the 0.25 mg starting dose requires only 5 units - at the lower limit of measurability. A 30-unit syringe provides finer graduation marks. At 2.5 mg/mL (5 mg vial + 2 mL BAC water), the starting dose is a comfortable 10 units and all tiers fit within a 100-unit syringe.
Peptigrity does not recommend a dose; the amounts below are the approved label's and the doses studied in SUSTAIN-6, SURMOUNT-5 and STEP UP, each with its source. The label starts at 0.25 mg weekly and escalates over months to 2.4 mg weekly for weight management, with 7.2 mg approved in March 2026. Semaglutide is approved for chronic use, so this is maintenance therapy rather than a course. Which rung anyone is on, and when they move, belongs to their prescriber rather than to a chart.
| Route | Amount | Frequency | Duration | Evidence level |
|---|---|---|---|---|
| Subcutaneous | 0.25 mg starting dose | Once weekly | Escalation phase | Approved label |
| Subcutaneous | 0.5 mg and 1.0 mg | Once weekly | Doses used in SUSTAIN-6 over 104 weeks | Human RCT |
| Subcutaneous | 1.7 mg | Once weekly | A maximum-tolerated arm in SURMOUNT-5 | Human RCT |
| Subcutaneous | 2.4 mg weight-management dose | Once weekly | Chronic | Approved label |
| Subcutaneous | 7.2 mg high dose, approved March 2026 | Once weekly | 72 weeks in STEP UP | Approved label |
| Research-market vial | Chosen by the buyer | Chosen by the buyer | Chosen by the buyer | None |
The strengths themselves are documented: 0.5 and 1.0 mg weekly were the doses in SUSTAIN-6 (n=3,297), and 1.7 or 2.4 mg were the maximum tolerated doses semaglutide was given at in SURMOUNT-5. A “68-week” figure is a trial duration, not a treatment plan — STEP 1 stopped at 68 weeks because that was its design. The evidence behind each amount is set out in semaglutide: the nausea rate is 44.2%, not 73%.
At 5 mg/mL, 7.2 mg is 1.44 mL, or 144 units — more than a 1 mL barrel holds; at 2.5 mg/mL it is 288 units and will not fit either. The dose was approved in March 2026 on the strength of STEP UP, which randomised 1,407 participants and produced −20.7% at 72 weeks against −17.5% on 2.4 mg and −2.4% on placebo. The table below gives each documented amount in U-100 units at 10 mg/mL, the concentration that holds the top dose; the 2.5 and 5 mg/mL figures are in the tables above.
| Weekly amount | At 10 mg/mL |
|---|---|
| 0.25 mg | 2.5 units — poor resolution |
| 0.5 mg | 5 units |
| 1.0 mg | 10 units |
| 1.7 mg | 17 units |
| 2.4 mg | 24 units |
| 7.2 mg | 72 units |
No single concentration serves the whole ladder. A 2.5 mg/mL preparation reads the starting dose well and cannot deliver the top one; a 10 mg/mL preparation holds the top dose comfortably and reduces the starting dose to a smear between marks. The worked example below puts the same 7.2 mg at two concentrations.
| Step | At 5 mg/mL | At 10 mg/mL |
|---|---|---|
| Input: intended dose | 7.2 mg | 7.2 mg |
| Volume | 7.2 ÷ 5 = 1.44 mL | 7.2 ÷ 10 = 0.72 mL |
| Units | 144 units | 72 units |
| Fits a 1 mL barrel? | No | Yes |
The wrong response to the left-hand column is to split the dose across two draws and hope the total is right. The right response happens earlier, at the point the diluent goes in: the diluent volume is the only variable here you fully control, it is irreversible once added, and it should be chosen against the rung you are on rather than the rung you started at. Whether 7.2 mg is an appropriate amount for any individual is a prescriber's question and this page does not touch it.
Step 1 - Choose BAC Water Volume. Use 2.5 mg/mL as the default concentration. At this level, the 0.25 mg starting dose equals 10 units - easy to measure on any syringe. The BAC water calculator recommends volumes based on your dose and syringe.
Step 2 - Reconstitute. Swab both vial stoppers with alcohol. Inject BAC water slowly against the inside glass wall. Semaglutide dissolves within 1-2 minutes of gentle swirling. Solution should be clear and colourless. See reconstituting peptides step by step.
Step 3 - Store. Refrigerate at 2-8°C. Stable for approximately 28 days. See how to store peptides.
| Vial Size | At 0.25 mg/wk | At 0.5 mg/wk | At 1.0 mg/wk | At 2.4 mg/wk | Best For |
|---|---|---|---|---|---|
| 2 mg | 8 weeks | 4 weeks | 2 weeks | <1 week | Starting dose / trial |
| 3 mg | 12 weeks | 6 weeks | 3 weeks | ~1.25 weeks | Tier 1-2 |
| 5 mg | 20 weeks | 10 weeks | 5 weeks | ~2 weeks | Most popular |
| 10 mg | 40 weeks | 20 weeks | 10 weeks | ~4 weeks | Extended protocols |
Reconstituted semaglutide lasts approximately 28 days. Select a vial size that aligns with your 28-day consumption. For price comparisons, use the cost-per-dose calculator.
| Dose | At 2.5 mg/mL | At 5 mg/mL |
|---|---|---|
| 0.25 mg | 10 units | 5 units |
| 0.5 mg | 20 units | 10 units |
| 1.0 mg | 40 units | 20 units |
| 1.7 mg | 68 units | 34 units |
| 2.0 mg | 80 units | 40 units |
| 2.4 mg | 96 units | 48 units |
Formula: Units = (Dose in mg ÷ Concentration in mg/mL) × 100. For a detailed walkthrough, see the how to calculate peptide doses guide.
Every figure above assumes the vial contains what the label says. A vial can be 99% pure and still hold substantially less peptide than claimed, because purity is a proportion and net content is a quantity. The worked example below carries an illustrative shortfall through the same 48-unit draw.
| Step | Label assumption | If the batch assays at 8.5 mg |
|---|---|---|
| Vial label | 10 mg | 10 mg |
| Peptide mass present | 10 mg | 8.5 mg |
| Diluent | 2 mL | 2 mL |
| Concentration | 5 mg/mL | 4.25 mg/mL |
| A 48-unit draw delivers | 2.4 mg | 2.04 mg |
| Units needed for 2.4 mg | 48 units | 56.5 units |
The 8.5 mg figure in that right-hand column is an illustration, not a measurement. Peptigrity does not publish a fill-variance range for semaglutide, because our fact base does not carry one. Where a net-content figure exists for your batch, calculate from the assay rather than from the label; see why 10 mg isn't 10 mg. The reverse dose calculator runs the check backwards, from a draw you have already made to the amount it delivered.
FDA has received “multiple reports of adverse events... that may be related to dosing errors associated with compounded injectable semaglutide products”; as of 30 November 2024 it had received more than 392 adverse event reports for compounded semaglutide. Those are spontaneous reports rather than trial data. The errors below account for most of the damage, and they are not equally visible.
Reverse check: units ÷ 100 × concentration should return your dose; any answer that does not match means one of the three inputs is wrong. Injection-technique errors — reusing a transfer needle, injecting into a reactive site, recapping a sharp — are covered in how to inject peptides.
Some compounding pharmacies add vitamin B12 (cyanocobalamin) to semaglutide, giving the solution a distinctive pink or red colour. This is normal. B12 is added as a supplement, not a pharmacological synergist. The dosing math for semaglutide remains identical. Enter the semaglutide milligrams on the vial label (not the B12 amount) as the vial size.
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Receptor targets | GLP-1 only | Dual: GIP + GLP-1 |
| Starting dose | 0.25 mg weekly | 2.5 mg weekly |
| Maximum dose | 2.4 mg weekly | 15 mg weekly |
| Common vial sizes | 2, 3, 5, 10 mg | 5, 10, 15, 30, 60 mg |
| Common concentration | 2.5-5 mg/mL | 5-15 mg/mL |
For a tirzepatide-specific calculator, see the tirzepatide calculator. For a full comparison, see comparing semaglutide and tirzepatide.
Semaglutide is one of the most counterfeited peptides in the research market due to its high demand and brand-name recognition (Ozempic, Wegovy). Quality verification before reconstitution is essential.
3 verification steps:
1. Check the Certificate of Analysis. The vendor's CoA should show HPLC purity of ≥97% and mass spectrometry identity confirmation matching semaglutide's molecular weight of 4,113.58 Da. Semaglutide contains a C18 fatty diacid linker - mass spec should confirm this modification. For guidance on interpreting CoAs, see red flags in peptide certificates of analysis.
2. Cross-reference against independent lab tests. Vendor CoAs are self-reported. Independent third-party test data published on Peptigrity's lab test results are community-submitted and verified by accredited laboratories. Check whether the vendor has independent semaglutide test data before purchasing.
3. Inspect the powder. Semaglutide lyophilised powder should be white to off-white, dry, and form a compact cake or loose powder. Discolouration (yellow, brown) or wet clumping suggests degradation or improper manufacturing. For a complete pre-purchase quality framework, see how to verify peptide quality before you buy.
At 2.5 mg/mL (5 mg vial + 2 mL BAC water): 0.25 mg = 10 units. At 5 mg/mL (5 mg vial + 1 mL): 0.25 mg = 5 units. The 2.5 mg/mL concentration provides more measurable draws and is commonly cited as the default.
2 mL produces 2.5 mg/mL - every dose tier from 0.25 mg (10 units) through 2.4 mg (96 units) fits within a 100-unit syringe. 1 mL produces 5 mg/mL - smaller draws but the 0.25 mg starting dose drops to 5 units, difficult to measure accurately. The BAC water calculator recommends volumes based on your dose and syringe.
The colour indicates vitamin B12 (cyanocobalamin) was added to the formulation. This is normal. Plain semaglutide without B12 reconstitutes to a clear, colourless solution. If your plain semaglutide produces a coloured solution, discard it.
Approximately 28 days at 2-8°C in bacteriostatic water. Unreconstituted powder at -20°C maintains integrity for months. See how to store peptides.
All three contain the same 31-amino-acid GLP-1 receptor agonist. Ozempic is FDA-approved for type 2 diabetes. Wegovy is approved for weight management. Both ship as pre-filled pens. Compounded semaglutide is produced by pharmacies under FDA 503A/503B regulations as lyophilised powder requiring reconstitution.
Not at 5 mg/mL, where it works out to 1.44 mL or 144 units against a 100-unit barrel. At 10 mg/mL the same dose is 0.72 mL, or 72 units, which does fit. The dose was approved in March 2026 on STEP UP, which produced 20.7% mean weight loss at 72 weeks in 1,407 participants.
Change the concentration rather than estimating between graduations. Below roughly two units the marks stop being informative, and the fix is upstream: reconstituting with more diluent lowers the concentration and raises the number of units for the same amount. That decision has to be made before the diluent goes in, because it cannot be undone afterwards.